* Cesca Therapeutics provides update on FDA review of
investigational device exemption supplement for Surgwerks CLI
pivotal trial
Source text for Eikon:
Further company coverage:
(Bengaluru…
The post BRIEF-Cesca Therapeutics provides update on FDA review of Surgwerks CLI pivotal trial appeared first on NASDAQ.